| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 309.84B | 293.14B | 285.68B | 288.87B | 258.08B | 231.48B |
| Gross Profit | 32.03B | 28.72B | 26.08B | 21.88B | 9.72B | 18.17B |
| EBITDA | 15.26B | 11.49B | 11.42B | 9.10B | -3.32B | 6.17B |
| Net Income | 8.15B | 6.63B | 7.27B | 5.25B | -7.46B | 2.65B |
Balance Sheet | ||||||
| Total Assets | 249.80B | 277.80B | 264.52B | 252.43B | 237.81B | 226.57B |
| Cash, Cash Equivalents and Short-Term Investments | 37.49B | 39.67B | 32.12B | 58.71B | 38.65B | 34.17B |
| Total Debt | 22.67B | 27.20B | 55.02B | 22.21B | 22.66B | 26.92B |
| Total Liabilities | 148.27B | 175.13B | 163.73B | 156.41B | 144.74B | 123.06B |
| Stockholders Equity | 100.49B | 101.64B | 99.97B | 95.25B | 92.49B | 102.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 38.53B | -55.69B | 19.73B | 10.24B | 8.28B |
| Operating Cash Flow | 0.00 | 41.20B | -54.02B | 20.39B | 12.20B | 11.63B |
| Investing Cash Flow | 0.00 | -1.59B | -1.40B | 2.40B | -476.00M | -3.75B |
| Financing Cash Flow | 0.00 | -31.88B | 28.52B | -2.76B | -7.53B | -3.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥142.83B | 9.06 | ― | 3.22% | 12.23% | 43.29% | |
79 Outperform | ¥114.04B | 10.36 | ― | 3.81% | 0.82% | 30.84% | |
76 Outperform | ¥178.67B | 10.32 | ― | 3.44% | 11.25% | 36.92% | |
75 Outperform | ¥125.75B | 8.40 | ― | 3.13% | 5.39% | 33.02% | |
68 Neutral | ¥146.46B | 9.00 | ― | 2.89% | 20.38% | 128.85% | |
64 Neutral | ¥106.11B | 13.33 | ― | 2.13% | 7.22% | 21.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |